Witor Ribeiro Ferraz

Witor Ribeiro Ferraz

Auto-generated profile, based on publicly available information

Witor Ribeiro Ferraz

Faculdade de Ciências Farmacêuticas, Universidade de São Paulo; Av. Prof. Lineu Prestes, 580, São Paulo, SP, 05508-000, Brasil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2020 in Future Medicinal Chemistry
Verified
Journal Article
Open access
WFWitor Ribeiro Ferraz
Witor Ribeiro Ferraz
RGRenan Augusto Gomes
Renan Augusto Gomes
ANAndre Luis S Novaes
Andre Luis S Novaes
GTGustavo Trossini
Gustavo Trossini
Aim: The identification of drugs for the coronavirus disease-19 pandemic remains urgent. In this manner, drug repurposing is a suitable strategy, saving resources and time normally spent during reg... Graphical abstract

1 January 2024 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
ALAdenilson Lima
Adenilson Lima
APAndré Penteado
André Penteado
JJJullyane de Jesus
Jullyane de Jesus
VPVanessa de Paula
Vanessa de Paula
WFWitor Ferraz
Witor Ferraz
GTGustavo Trossini
Gustavo Trossini
Structure-based virtual screening (SBVS) is an important approach that makes the first stages of drug development and repurposing processes faster and more efficient. Advances in experimental techniques and in silico computational modeling have contributed significantly to the characterization of diverse biological targets. Combined with the rapidly growing number of chemical compounds available in virtual databases, these advances enable the effective application of SBVS for prioritization of putative bioactive compounds to treat a wide range of pathologies. Techniques such as molecular docking, along with the utilization of pharmacophore models, are commonly employed for screening large databases of compounds, providing a solid foundation for employing SBVS in drug development pipelines. This review comprehensively analyzes recent advancements and strategies employed in the field of SBVS and explores methodologies for validation, limitations, and challenges associated with this approach. Through a series of case studies across different therapeutic targets, we demonstrate SBVS’s versatility and efficacy in identifying potential therapeutic agents. However, challenges remain, and understanding these is crucial for maximizing SBVS’s potential. We address these challenges, offering insights into the current limitations and future prospects of SBVS in drug development.